These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7673025)

  • 21. Radiobiological modelling of dose-gradient effects in low dose rate, high dose rate and pulsed brachytherapy.
    Armpilia C; Dale RG; Sandilos P; Vlachos L
    Phys Med Biol; 2006 Sep; 51(17):4399-411. PubMed ID: 16912389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of patient variation on standard- and hypo-fractionated radiotherapy of prostate cancer.
    Xiong W; Li J; Ma CM
    Phys Med Biol; 2005 Apr; 50(7):1483-92. PubMed ID: 15798338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluating the influence of setup uncertainties on treatment planning for focal liver tumors.
    Balter JM; Brock KK; Lam KL; Tatro D; Dawson LA; McShan DL; Ten Haken RK
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):610-4. PubMed ID: 16095848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The comparison of radiotherapy techniques for treatment of the prostate cancer: the three-field vs. the four-field.
    Milecki P; Piotrowski T; Dymnicka M
    Neoplasma; 2004; 51(1):64-9. PubMed ID: 15004663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compatibility of the linear-quadratic formalism and biologically effective dose concept to high-dose-per-fraction irradiation in a murine tumor.
    Otsuka S; Shibamoto Y; Iwata H; Murata R; Sugie C; Ito M; Ogino H
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1538-43. PubMed ID: 22115556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Further radiobiologic modeling of palliative radiotherapy: use of virtual trials.
    Jones B; Dale RG
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):221-9. PubMed ID: 17707276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological effective dose for comparison and combination of external beam and low-dose rate interstitial brachytherapy prostate cancer treatment plans.
    Jani AB; Hand CM; Lujan AE; Roeske JC; Zagaja GP; Vijayakumar S; Pelizzari CA
    Med Dosim; 2004; 29(1):42-8. PubMed ID: 15023392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Equivalent uniform dose concept evaluated by theoretical dose volume histograms for thoracic irradiation.
    Dumas JL; Lorchel F; Perrot Y; Aletti P; Noel A; Wolf D; Courvoisier P; Bosset JF
    Phys Med; 2007 Mar; 23(1):16-24. PubMed ID: 17568539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isotope selection for permanent prostate implants? An evaluation of 103Pd versus 125I based on radiobiological effectiveness and dosimetry.
    Dicker AP; Lin CC; Leeper DB; Waterman FM
    Semin Urol Oncol; 2000 May; 18(2):152-9. PubMed ID: 10875458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological dose representation for carbon-ion radiotherapy of unconventional fractionation.
    Kanematsu N; Inaniwa T
    Phys Med Biol; 2017 Feb; 62(3):1062-1075. PubMed ID: 28081010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tables of equivalent dose in 2 Gy fractions: a simple application of the linear quadratic formula.
    Barton M
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):371-8. PubMed ID: 7836091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The linear-quadratic transformation of dose-volume histograms in fractionated radiotherapy.
    Wheldon TE; Deehan C; Wheldon EG; Barrett A
    Radiother Oncol; 1998 Mar; 46(3):285-95. PubMed ID: 9572622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological optimization of heterogeneous dose distributions in systemic radiotherapy.
    Strigari L; D'Andrea M; Maini CL; Sciuto R; Benassi M
    Med Phys; 2006 Jun; 33(6):1857-66. PubMed ID: 16872093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generalized Multi-Hit Model of Radiation-Induced Cell Survival with a Closed-Form Solution: An Alternative Method for Determining Isoeffect Doses in Practical Radiotherapy.
    Zhao L; Chen X; Tian J; Shang Y; Mi D; Sun Y
    Radiat Res; 2020 Apr; 193(4):359-371. PubMed ID: 32031917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The radiobiology of conventional radiotherapy and its application to radionuclide therapy.
    Dale R; Carabe-Fernandez A
    Cancer Biother Radiopharm; 2005 Feb; 20(1):47-51. PubMed ID: 15778580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimization of radiotherapy dose-time fractionation with consideration of tumor specific biology.
    Yang Y; Xing L
    Med Phys; 2005 Dec; 32(12):3666-77. PubMed ID: 16475766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules?
    Shibamoto Y; Miyakawa A; Otsuka S; Iwata H
    J Radiat Res; 2016 Aug; 57 Suppl 1(Suppl 1):i76-i82. PubMed ID: 27006380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The dependence of optimal fractionation schemes on the spatial dose distribution.
    Unkelbach J; Craft D; Salari E; Ramakrishnan J; Bortfeld T
    Phys Med Biol; 2013 Jan; 58(1):159-67. PubMed ID: 23221166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Monte Carlo approach to the microdosimetric kinetic model to account for dose rate time structure effects in ion beam therapy with application in treatment planning simulations.
    Manganaro L; Russo G; Cirio R; Dalmasso F; Giordanengo S; Monaco V; Muraro S; Sacchi R; Vignati A; Attili A
    Med Phys; 2017 Apr; 44(4):1577-1589. PubMed ID: 28130821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.